The Tsimshian people of coastal British Columbia and southern Alaska experienced changes in genetic diversity following contact with Europeans.
The institute will use the funds to continue combining genomic and digital technologies with bioinformatics to advance medical research and clinical care.
An exome- and expression-based analysis of 304 DLBCL cases led to five molecular subtypes, offering insights into disease pathogenesis and treatment outcomes.
A Phase III randomized trial uncovered enhanced carboplatin response in advanced triple-negative breast cancer patients with germline mutations affecting BRCA1/2.
Revenues fell as an increase in sales of test cartridges for its Unyvero molecular diagnostic instrument was offset by a decline in system and service sales.
The five CROs will be able to offer DSP analyses to their customers through a technology access program ahead of NanoString's planned platform launch in 2019.
The firm said it will use the funds to continue developing and then commercialize its next-generation sequencing technology.
Last week, GenomeWeb's readers were most interested in a new CRISPR company cofounded by Jennifer Doudna.
The panel is designed to measure genetic markers in whole-blood samples in order to predict which patients are likely to experience a severe, relapsing form of the disease.
An international team of researchers combined data from seven cohorts to uncover 30 novel depression-linked loci, including ones that overlap with schizophrenia.
The company said it will use the proceeds for the US commercial launch of its Unyvero molecular diagnostic platform, among other things.
Upon completion of the transaction, Rosetta will become a privately held subsidiary of Genoptix and its shares will cease to trade on the Nasdaq.
The firm is selling BioServe to Reprocell as part of Cancer Genetics' transformation and strategic plan to bring itself to profitability.
The companies will work together to enable Foundation Medicine’s assays to be offered across Dian’s network of laboratories in China.
The program is open to anyone in the US or in Puerto Rico who is suspected of having SMA or needs confirmation of the disease via genetic testing.
Illumina launched the accelerator program in 2014 to provide biotech startups with investment capital, genomics expertise, and other resources.
The company said test volume rose 87 percent to 186,000 during the quarter.
The team paired the SHERLOCK platform developed in Feng Zhang's lab with a protocol that detects viruses directly from bodily fluids in less than two hours.
The company said it plans to develop a CRISPR-enabled platform capable of detecting any biomarker or disease containing DNA or RNA.
Three new studies have used single-cell RNA sequencing methods to follow cell type trajectories over the course of zebrafish and Western claw-toed frog development.
Speakers at the Association for Biomolecular Resource Facilities annual meeting gave advice on preparing for and recovering from hurricanes.
Hong Kong-based Rainbow Genomics will provide exome sequencing while UCLA will interpret the data and deliver a clinical report.
US News & World Report writes that genetic testing of lung tumors can help identify treatments for patients.
A team of researchers plans to sample Loch Ness for environmental DNA, according to Newsweek.
The New York Times writes about the appearance of mosaicism in healthy people.
In PNAS this week: insecticide resistance patterns Anopheles gambiae mosquito, transcriptome patterns in Pseudomonas aeruginosa during infection, and more.